FDA Adverse Event
Injury
Summary report: N
SP Ø 4.1MM RN, SLACTIVE® 12MM, TIZR, NTP
MDR report key: 13119818
·
Received December 30, 2021
Report
- Report Number
- 0001222315-2021-22987
- Event Type
- Injury
- Date Received
- December 30, 2021
- Date of Event
- November 18, 2021
- Report Date
- December 30, 2021
- Manufacturer
- INSTITUT STRAUMANN AG
- Product Code
- DZE
- UDI-DI
- 07630031715982
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- CO, US
- Reporter Occupation
- DENTIST
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2018 IN ADA 13. ON (B)(6) 2021-11-18, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III AND FAIR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: BLEEDING AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2016500 | SP Ø 4.1MM RN, SLACTIVE® 12MM, TIZR, NTP | ENDOSSEOUS DENTAL IMPLANT | DZE | INSTITUT STRAUMANN AG | SLActive Roxolid TL | 07630031715982 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Male | Required Intervention |